Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Influence of Strategy Training on Disability for Older Adults With Mild Cognitive Impairment
Authors not listed
University of Pittsburgh · 2019
Abstract
Loss of cognitive abilities leading to Alzheimer's disease is progressive and destructive, leaving older adults disabled and unable to recall their past. The number of older adults with Alzheimer's disease is expected to triple by the year 2050, yet little research examines amyloid beta deposition, executive function, and progression of disability. This study will test the influence of a novel and promising non-pharmacological intervention, Strategy Training, on the progression of disability in a sample of 150 older adults with Mild Cognitive Impairment who have the option to complete a Positron Emission Tomography (PET) Imaging with Pittsburgh Compound B (PiB).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2019). Influence of Strategy Training on Disability for Older Adults With Mild Cognitive Impairment. <em>University of Pittsburgh</em>. https://clinicaltrials.gov/study/NCT03913637
Vancouver
Anonymous. Influence of Strategy Training on Disability for Older Adults With Mild Cognitive Impairment. University of Pittsburgh. 2019.
BibTeX
@misc{anon2019Influe,
title = {Influence of Strategy Training on Disability for Older Adults With Mild Cognitive Impairment},
author = {Anonymous},
journal = {University of Pittsburgh},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New York State Psychiatric Institute 2010
Open access · US-GOV
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Posit Science Corporation 2004
Open access · US-GOV
Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease
Biomed Industries, Inc. 2018
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment
Bruyère Health Research Institute. 2016
Open access · US-GOV
Adaptive Cognitive Training in Healthy Older Adults
Journal of Experimental & Clinical Medicine 2014
Preprint · CC-BY
Epigenomics of Alzheimer's Disease
Vanderbilt University Medical Center 2026
Open access · US-GOV